Moviprep

Polyethylene glycol 3350 with electrolytes and ascorbic acid, the active ingredient in Moviprep, is an osmotic laxative presented as a powder for oral solution for oral use. It is employed to cleanse the bowel before diagnostic procedures such as colonoscopy and sigmoidoscopy in adult patients. GNH USA supplies Moviprep as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moviprep is an osmotic bowel‑cleansing agent used in gastrointestinal diagnostic pathways. - Colonoscopy preparation: provides thorough colon cleansing to allow clear visualization during colonoscopy. - Sigmoidoscopy preparation: clears the distal colon and rectum to facilitate accurate sigmoidoscopic examination. - Other gastrointestinal diagnostic procedures: creates an adequately cleared bowel for procedures such as virtual colonoscopy or capsule endoscopy.

Moviprep may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate feeling of queasiness. - Abdominal cramping: intermittent discomfort during bowel evacuation. - Diarrhoea: loose stools occurring during the cleansing process. - Bloating: sensation of abdominal fullness. - Flatulence: increased intestinal gas. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal sodium, potassium or chloride levels. - Dehydration: marked loss of body water leading to dizziness or low blood pressure. - Renal impairment worsening: decline in kidney function in susceptible individuals. - Allergic reaction: rash, itching, swelling or difficulty breathing.

Before using Moviprep, consider the following safety measures. - Assess renal function: evaluate kidney health, especially in patients with chronic kidney disease. - Review electrolyte status: check baseline sodium, potassium and chloride levels. - Evaluate gastrointestinal obstruction risk: avoid use if there is known or suspected bowel blockage. - Consider pregnancy and lactation: use only if the prescriber determines potential benefits outweigh risks. - Monitor fluid intake: encourage adequate oral hydration during the preparation period. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Moviprep can interact with other medicines that affect fluid or electrolyte balance.

Major Interactions (Avoid): - Loop diuretics: may exacerbate dehydration and electrolyte loss. - Potassium‑sparing diuretics: increase risk of hyperkalaemia when combined. - Sodium‑containing laxatives: can cause excessive sodium load.

Moderate Interactions (Monitor Closely): - Antihypertensives: monitor blood pressure for orthostatic changes. - NSAIDs: may affect renal function when combined with large fluid shifts. - Oral rehydration solutions: adjust electrolyte content to avoid overload.